Patents by Inventor Enrique Llaudet

Enrique Llaudet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11382867
    Abstract: A pharmaceutical composition comprising apomorphine (APO) in a solid crystalline form, wherein the solid crystalline form is an APO·palmitic acid cocrystal solid particle crystalline form.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 12, 2022
    Assignee: LEUKOS BIOTECH, S. L.
    Inventors: Enrique Llaudet Carles, Nicolas Tesson, Montserrat Trilla Castaño
  • Publication number: 20200405648
    Abstract: A pharmaceutical composition comprising apomorphine (APO) in a solid crystalline form, wherein the solid crystalline form is an APO·palmitic acid cocrystal solid particle crystalline form.
    Type: Application
    Filed: January 15, 2019
    Publication date: December 31, 2020
    Inventors: Enrique LLAUDET CARLES, Nicolas TESSON, Montserrat TRILLA CASTAÑO
  • Publication number: 20060222564
    Abstract: Method of Producing Sol-gels and Sol-gel Biosensors. The invention discloses a method of producing a layer of sol-gel on a substrate comprising the steps of: (a) providing a acidified sol suspension; (b) at least partially neutralising the acidified sol suspension to form a neutralised sol suspension; (c) contacting an electrically conductive surface with the neutralised sol suspension; and (d) applying an electrical potential to the electrically conductive surface to cause a layer of sol-gel to form on the surface of the electrically conductive surface. Preferably, the neutralised sol-gel has a biological material, such as an enzyme added. Biosensors obtained by using the method are also provided.
    Type: Application
    Filed: November 18, 2003
    Publication date: October 5, 2006
    Inventors: Nicholas Dale, Enrique Llaudet, Magali Droniou